Humacyte Correlations
| HUMA Stock | USD 0.94 0.05 5.62% |
The current 90-days correlation between Humacyte and Tharimmune is 0.19 (i.e., Average diversification). The correlation of Humacyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Humacyte Correlation With Market
Excellent diversification
The correlation between Humacyte and DJI is -0.58 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Humacyte Stock
| 0.68 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.83 | EDIT | Editas Medicine | PairCorr |
| 0.75 | ABP | Abpro Holdings | PairCorr |
| 0.88 | QSI | QuantumSi | PairCorr |
| 0.8 | GNLX | Genelux Common | PairCorr |
| 0.81 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.78 | LYRA | Lyra Therapeutics | PairCorr |
| 0.88 | MBIO | Mustang Bio | PairCorr |
| 0.65 | MREO | Mereo BioPharma Group | PairCorr |
| 0.64 | PROK | ProKidney Corp | PairCorr |
| 0.74 | PRQR | ProQR Therapeutics | PairCorr |
| 0.82 | ACXP | Acurx Pharmaceuticals LLC | PairCorr |
Moving against Humacyte Stock
| 0.74 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.65 | ENGN | enGene Holdings Common | PairCorr |
| 0.62 | DSGN | Design Therapeutics | PairCorr |
| 0.5 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.41 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.68 | ANNX | Annexon | PairCorr |
| 0.62 | AVE | Avecho Biotechnology | PairCorr |
| 0.61 | MRKR | Marker Therapeutics | PairCorr |
| 0.6 | SLDB | Solid Biosciences LLC | PairCorr |
| 0.51 | AVCR | Avricore Health | PairCorr |
| 0.48 | BOLT | Bolt Biotherapeutics | PairCorr |
| 0.32 | SVRA | Savara Inc | PairCorr |
| 0.77 | SMFNF | Sumitomo Mitsui Financial | PairCorr |
| 0.76 | SMFG | Sumitomo Mitsui Financial Normal Trading | PairCorr |
| 0.73 | DBVT | DBV Technologies | PairCorr |
| 0.7 | MZHOF | Mizuho Financial Normal Trading | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Humacyte Stock performing well and Humacyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Humacyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GOVX | 5.33 | (2.41) | 0.00 | (0.83) | 0.00 | 9.38 | 42.89 | |||
| BLRX | 2.59 | (0.27) | 0.00 | (0.19) | 0.00 | 5.20 | 13.04 | |||
| THAR | 5.48 | 0.50 | 0.08 | 0.40 | 5.92 | 11.55 | 40.06 | |||
| AIMD | 4.50 | (0.89) | 0.00 | (0.22) | 0.00 | 12.30 | 38.73 | |||
| OSRH | 6.34 | (0.17) | 0.00 | 0.02 | 6.57 | 15.25 | 43.23 | |||
| LPCN | 5.03 | 2.00 | 0.39 | (14.40) | 3.32 | 15.95 | 33.09 | |||
| ICU | 5.02 | (1.17) | 0.00 | (0.46) | 0.00 | 9.58 | 34.66 |
Humacyte Corporate Management
| Harold Alterson | Senior Quality | Profile | |
| Sabrina Osborne | Executive People | Profile | |
| Dale Sander | Chief CFO | Profile | |
| Heather Connelly | Senior Quality | Profile | |
| William Scheessele | Chief Officer | Profile | |
| Yang MD | Chief Officer | Profile |